SCHEMBL6982299

SCHEMBL6982299

COc1cccc(-c2ccc3c(-c4cccnc4)csc3c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 6/20 0.51
CYP11B1 P15538 5/20 0.51
CYP17A1 P05093 4/20 0.51
CYP19A1 P11511 3/20 0.51
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP3A4 P08684 3/20 0.47
CYP1A2 P05177 2/20 0.47
TP53 P04637 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6985271 0.99 CYP11B2 (0.50) CYP11B2CYP11B1CYP17A1CYP19A1KDM4E
SCHEMBL6982148 0.91 CYP11B2 (0.52) CYP11B2CYP11B1CYP17A1CYP19A1KDM4E
SCHEMBL6981655 0.90 KDM4E (0.55) CYP11B2CYP11B1CYP17A1CYP19A1KDM4E
Hydrochloric Acid SCHEMBL6982572 0.89 KDM4E (0.54) CYP11B2CYP11B1CYP17A1CYP19A1KDM4E
SCHEMBL6983025 0.88 KDM4E (0.49) CYP11B2CYP11B1CYP17A1CYP19A1KDM4E
Hydrochloric Acid SCHEMBL6986512 0.87 KDM4E (0.48) CYP11B2CYP11B1CYP17A1CYP19A1KDM4E
SCHEMBL6985509 0.87 MKNK1 (0.46) CYP11B2CYP11B1CYP19A1ALDH1A1HPGD
Hydrochloric Acid SCHEMBL6979381 0.86 MKNK1 (0.45) CYP11B2CYP11B1CYP19A1ALDH1A1HPGD
SCHEMBL6985848 0.86 DYRK1A (0.50) CYP11B2CYP11B1CYP17A1CYP19A1ALDH1A1
SCHEMBL6982439 0.85 SMN1; SMN2 (0.53) CYP11B2CYP11B1CYP17A1CYP19A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030130340-A1 Novel benzothiophene derivatives DAIICHI PHARMACEUTICAL CO. LTD. 2003-07-10 US disclosed
EP-1283209-A1 NOVEL BENZOTHIOPHENE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130340-A1 Novel benzothiophene derivatives CYP17A1, CYP21A2, HSD17B1 CYP11B2 18/4885CYP11B1 8/4885CYP17A1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.